InMode (NASDAQ:INMD – Get Free Report) is expected to be announcing its Q3 2026 results before the market opens on Wednesday, November 11th. Analysts expect InMode to announce earnings of $0.3220 per share and revenue of $91.58 million for the quarter. Individuals can check the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Wednesday, November 11, 2026 at 8:30 AM ET.
InMode Stock Up 1.4%
INMD stock opened at $13.51 on Tuesday. InMode has a 52-week low of $12.72 and a 52-week high of $16.67. The stock’s fifty day simple moving average is $14.22 and its 200-day simple moving average is $14.32. The stock has a market capitalization of $776.55 million, a price-to-earnings ratio of 11.36 and a beta of 1.98.
Wall Street Analyst Weigh In
Separately, Weiss Ratings cut InMode from a “sell (d+)” rating to a “sell (d)” rating in a report on Monday, November 2nd. One equities research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, InMode has a consensus rating of “Hold” and a consensus target price of $16.00.
View Our Latest Report on INMD
InMode Company Profile
InMode Ltd. (NASDAQ: INMD) is a global medical technology company that develops and commercializes energy-based platforms for aesthetic and medical treatments. Its systems are designed to support minimally invasive and noninvasive procedures performed by physicians and other healthcare professionals.
The company’s product portfolio includes platforms and handpieces used in facial and body contouring, skin resurfacing, skin tightening, hair removal, and women’s health applications. Its technologies include radio-frequency and other energy-based treatments, with products such as Morpheus8, BodyTite, FaceTite, Optimas, and EmpowerRF serving a range of clinical and aesthetic needs.
Founded in 2008, InMode sells its products through direct sales and distribution channels to medical practices, clinics, and other healthcare providers.
Read More
- Five stocks we like better than InMode
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.
